Mesenchymal stem cell use in acute tendon injury: in vitro tenogenic potential vs. in vivo dose response

HIGHLIGHTS

  • who: Kristin Bowers and colleagues from the Large Animal Clinical Sciences, University of Tennessee College of Veterinary Medicine, Knoxville, TN, USA have published the article: Mesenchymal Stem Cell Use in Acute Tendon Injury: In Vitro Tenogenic Potential vs. In Vivo Dose Response, in the Journal: Bioengineering 2022, 407 of /2022/
  • what: The authors aimed to isolate a rat mesenchymal stem cell lineage for in vitro and in vivo use to assess the effects of growth factor exposure in vitro on cell morphology behavior and tendon-associated glycoprotein production and to assess the therapeutic potential of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?